Immunosurveillance
Articles tagged with Immunosurveillance
MD Anderson shares latest research breakthroughs
Researchers at MD Anderson have made significant discoveries in the treatment of rare bile duct cancers, with zanidatamab showing promising results. Additionally, a study identified RASH3D19 as a target to overcome treatment resistance in KRAS-mutant cancers.
LJI scientists explore the importance of sex-based differences in the immune system
Researchers at La Jolla Institute for Immunology examine how genetics, sex hormones, and environmental factors shape the immune system. Women have a stronger immune response due to their XX chromosomes and estrogen, but also face an increased risk of autoimmune diseases.
How cancer cells trick the immune system by altering mitochondria
Researchers discover mitochondrial transfer between cancer cells and immune cells as a key immune evasion strategy. Cancer cells can reshape the tumor microenvironment to weaken tumor-infiltrating lymphocytes, and mitochondria play a significant role in this process.
New mechanism: How cancer cells escape the immune system
A new mechanism has been found by which tumor cells escape the immune system, involving a protein called IRGQ. Studies have shown that suppressing IRGQ can trigger a stronger immune response against cancer cells, leading to improved survival rates in liver cancer patients.
Study reveals new insights into immune system role in lung cancer risk
A recent study has shed light on the vital role of the immune system in lung cancer risk, particularly among smokers. The research found that individuals with heterozygosity at HLA-II genes experienced a decreased risk of lung cancer.
Cancer patients treated with immunotherapy can safely receive mRNA COVID-19 vaccines, according to JNCCN study
Researchers analyzed 408 patients receiving immune checkpoint inhibitor therapy and found no increased risk of side effects from receiving both immunotherapy and the vaccine. The study supports NCCN's recommendations for COVID-19 vaccination in people with cancer, citing strong protection against severe COVID-19 for all variants.